Marshall Wace’s Imperva, Inc. IMPV Stock Holding History

Marshall Wace’s Portfolio IMPV Stock Details IMPV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-648	Closed	-$36K	–	2266
2018 Q4	$36K	Buy	+648	New	+$35.2K	﹤0.01%	1486
2018 Q3	–	Sell	-14,398	Closed	-$695K	–	1341
2018 Q2	$695K	Sell	14,398 -19,999	-58%	-$957K	0.01%	546
2018 Q1	$1.49M	Buy	+34,397	New	+$1.54M	0.06%	227
2016 Q4	–	Sell	-107,046	Closed	-$5.75M	–	1209
2016 Q3	$5.75M	Buy	+107,046	New	+$4.97M	0.04%	384
2016 Q1	–	Sell	-12,118	Closed	-$767K	–	1276
2015 Q4	$767K	Buy	+12,118	New	+$825K	0.01%	751
2014 Q4	–	Sell	-19,603	Closed	-$563K	–	1061
2014 Q3	$563K	Buy	+19,603	New	+$532K	0.01%	630

Marshall Wace's IMPV Position: Q1 2019 in Review

Marshall Wace sold out of Imperva, Inc. (IMPV) in Q1 2019, closing a stake of 648 shares — an estimated $36K sold.

Marshall Wace first reported a position in IMPV in Q3 2014 and held it in 6 quarters. The position peaked at $5.75M in Q3 2016. 0 funds tracked by Wall St. Rank hold IMPV as of Q1 2019.

Marshall Wace reported no remaining Imperva, Inc. position as of Q1 2019 after selling out during the quarter.
Marshall Wace sold 648 Imperva, Inc. shares in Q1 2019, an estimated $36K.
Marshall Wace first reported a position in Imperva, Inc. in Q3 2014 and held it in 6 quarters.
Marshall Wace's Imperva, Inc. position peaked at $5.75M in Q3 2016.
0 funds tracked by Wall St. Rank held Imperva, Inc. as of Q1 2019.

Based on Marshall Wace's 13F filing for Q1 2019, filed 14 May 2019.